Biolase, Inc. (BIOL) Financials
BIOL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 38.7 million | 32.9 million |
2023-06-30 | 39.6 million | 32.3 million |
2023-03-31 | 41.9 million | 33.8 million |
2022-12-31 | 38.2 million | 33.3 million |
BIOL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.8 million | 275000 |
2023-06-30 | -3.9 million | 84000 |
2023-03-31 | -6.2 million | 691000 |
2022-12-31 | -6.1 million | 612000 |
BIOL Net Income
No data available :(
BIOL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 7.8 million | - | 995000 |
2023-06-30 | 6.9 million | - | 2.1 million |
2023-03-31 | 6.5 million | - | 2.2 million |
2022-12-31 | 4.2 million | - | 1.9 million |
BIOL Shares Outstanding
BIOL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 182000 | 1.4 million | 2.7 million | 3.4 million |
2023-06-30 | 357000 | 1.4 million | 2.4 million | 6.2 million |
2023-03-31 | 587000 | 1.5 million | 2.5 million | 4.6 million |
2022-12-31 | 471000 | 2.1 million | 3.5 million | 6.5 million |
BIOL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 10.9 million | 7.2 million |
2023-06-30 | 14.3 million | 8.2 million |
2023-03-31 | 10.5 million | 7.1 million |
2022-12-31 | 14.1 million | 10.5 million |
BIOL
Price: $0.15
52 week price:
Earnings Per Share: -29.44 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 574700
Ebitda: -14.7 millionMarket Capitalization: 5.5 million
Average Dividend Frequency: 3